Work

Neoadjuvant chemotherapy plus trastuzumab in stage II/III breast cancer with low HER2 expression.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.1039

Authors: Qamar J. Khan, Anne O'Dea, Carol J. Fabian, Carol Sue Connor, Marilee McGinness, Joshua Matthew Varghise Mammen, Jamie Lynn Wagner, Stella Baccaray, Michelle Springer, Henry Yeh, Priyanka Sharma

Institutions: University of Kansas Medical Center, University of Kansas, The University of Kansas Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603408411

Cites:

Cited by: 2

Related to: 10